Your browser doesn't support javascript.
Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape.
McCarthy, Kevin R; Rennick, Linda J; Nambulli, Sham; Robinson-McCarthy, Lindsey R; Bain, William G; Haidar, Ghady; Duprex, W Paul.
  • McCarthy KR; Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. krm@pitt.edu pduprex@pitt.edu.
  • Rennick LJ; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Nambulli S; Laboratory of Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Robinson-McCarthy LR; Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Bain WG; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Haidar G; Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Duprex WP; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Science ; 371(6534): 1139-1142, 2021 03 12.
Article in English | MEDLINE | ID: covidwho-1063045
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
Zoonotic pandemics, such as that caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can follow the spillover of animal viruses into highly susceptible human populations. The descendants of these viruses have adapted to the human host and evolved to evade immune pressure. Coronaviruses acquire substitutions more slowly than other RNA viruses. In the spike glycoprotein, we found that recurrent deletions overcome this slow substitution rate. Deletion variants arise in diverse genetic and geographic backgrounds, transmit efficiently, and are present in novel lineages, including those of current global concern. They frequently occupy recurrent deletion regions (RDRs), which map to defined antibody epitopes. Deletions in RDRs confer resistance to neutralizing antibodies. By altering stretches of amino acids, deletions appear to accelerate SARS-CoV-2 antigenic evolution and may, more generally, drive adaptive evolution.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Neutralizing / Immune Evasion / Spike Glycoprotein, Coronavirus / SARS-CoV-2 / COVID-19 / Antibodies, Viral / Antigens, Viral Topics: Variants Limits: Humans Language: English Journal: Science Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Neutralizing / Immune Evasion / Spike Glycoprotein, Coronavirus / SARS-CoV-2 / COVID-19 / Antibodies, Viral / Antigens, Viral Topics: Variants Limits: Humans Language: English Journal: Science Year: 2021 Document Type: Article